Clinical Trial Update: Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device [Phase 1]

View source ↗

Summary

The Phase 1 study evaluating digital colposcopy with fluorescence spectroscopy for cervical neoplasia (TNC) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Neoplasia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cervical Neoplasia | Phase 1 | Status: WITHDRAWN